Curative effect of oxycontin on moderate and severe hepatalgia of primary liver cancer post-transcatheter arterial chemoembolization

Paper

Curative effect of oxycontin on moderate and severe hepatalgia of primary liver cancer post-transcatheter arterial chemoembolization

Published Jan 1, 2009 · Hao Ming-zh

Journal of Huaihai Medicine

0

Citations

0

Influential Citations

Semantic Scholar

Abstract

Objective To evaluate the efficacy and side effects of oxycontin(oxycodone hydrochloride controlled-release tablets)in the treatment of moderate to severe hepatalgia of primary liver cancer post-transcatheter arterial chemoembolization.Methods Oxycontin was administered at an initial dose of 10mg every 12 hours and the dose was increased to achieve pain relief.If the pain was decreased less than one grade after 24 hours,the dosage was increased to 20mg/12h the next day.If the pain was still decreased less than one grade,the dosage on the third day was increased to 30mg/12h.The maximum dosage was 40mg/12h.Results The overall relief rate from pain was 95.4%.95.2% in patients with moderate hepatalgia and 95.8% in patients with severe hepatalgia.Conclusion Oxycontin is safe and effective for moderate and severe hepatalgia of primary liver cancer post-transcatheter arterial chemoembolization.

Non-RCT

Study Snapshot

Oxycontin is a safe and effective treatment for moderate to severe hepatalgia in primary liver cancer patients after transcatheter arterial chemoembolization.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Curative effect of oxycontin on moderate and severe hepatalgia of primary liver cancer post-transcatheter arterial chemoembolization

References

Citations